TUMORGENESIS Trademark

Trademark Overview


On Thursday, March 11, 2021, a trademark application was filed for TUMORGENESIS with the United States Patent and Trademark Office. The USPTO has given the TUMORGENESIS trademark a serial number of 90573026. The federal status of this trademark filing is REGISTERED as of Tuesday, June 21, 2022. This trademark is owned by Predictive Oncology, Inc.. The TUMORGENESIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research services in the nature of providing cancer diagnostic and prognostic services, namely, growing cancer cells in tissue culture and assessing the cells for diagnostic and prognostic purposes
tumorgenesis

General Information


Serial Number90573026
Word MarkTUMORGENESIS
Filing DateThursday, March 11, 2021
Status700 - REGISTERED
Status DateTuesday, June 21, 2022
Registration Number6763949
Registration DateTuesday, June 21, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 5, 2022

Trademark Statements


Description of MarkThe mark consists of a blue circle with 6 white lines intersecting to a small orange circle inside the blue circle and to the right of the circle and the words TumorGenesis with an uppercase "T" and "G". The white background of the mark represents a transparent color and is not claimed as a feature of the mark.
Pseudo MarkTUMOR GENESIS
Indication of Colors claimedThe color(s) Blue, orange and white is/are claimed as a feature of the mark.
Goods and ServicesMedical research services in the nature of providing cancer diagnostic and prognostic services, namely, growing cancer cells in tissue culture and assessing the cells for diagnostic and prognostic purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 11, 2021
Primary Code042
First Use Anywhere DateFriday, August 14, 2020
First Use In Commerce DateFriday, August 14, 2020

Trademark Owner History


Party NamePredictive Oncology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEagan, MN 55121

Party NamePredictive Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEagan, MN 55121

Party NamePredictive Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEagan, MN 55121

Trademark Events


Event DateEvent Description
Tuesday, January 2, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, January 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 21, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 21, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, April 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 5, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, February 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 13, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 13, 2021NON-FINAL ACTION E-MAILED
Wednesday, October 13, 2021NON-FINAL ACTION WRITTEN
Thursday, October 7, 2021ASSIGNED TO EXAMINER
Saturday, June 12, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, June 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 15, 2021NEW APPLICATION ENTERED